Biomedical patents have been the subject of heated debate. Regulatory agencies such as the European Patent Office make small decisions with big implications, which escape scrutiny and revision, when they decide who has access to expensive diagnostic tests, whether human embryonic stem cells can be traded in markets, and under what circumstances human health is more important than animal welfare. Moreover, the administration of the Trade Related Aspects of Intellectual Property Rights by the World Trade Organization has raised considerable disquiet as it has arguably created grave health inequities. Those doubting the merits of the one size fits all approach ask whether priority should be given to serving the present needs of populations in dire need of medication or to promoting global innovation. The book looks in detail into the legal issues and ethical debates to ask the following three main questions: First, what are the ideas, goals, and broader ethical visions that underpin questions of governance and the legal reasoning employed by administrative agencies? Second, how can we democratize the decision making process of technocratic institutions such as the European Patent Office? Finally, how can we make the global intellectual property system more equitable? In answering these questions the book seeks to contribute to our understanding of the role and function of regulatory agencies in the regulation of the bioeconomy, explains the process of interpretation of legal norms, and proposes ways to rethink the reform of the patent system through the lens of legitimacy.
This book brings together well-known authors from the US, Europe and Asia who develop conceptual and regional perspectives on responsible innovation as well as exploring the prospects for further implementation of responsible innovation in ...
Stephen, Elizabeth Hervey, and Anjani Chandra. 2006. “Use of Infertility Services in the United States: 1995.” Family Planning Perspectives 32 (3): 132–37. Stephens, T., and J. McLean. 1993. Survey of Canadian Fertility Programs.
... Property Quarterly 189 Katerina Sideri , Bioproperty , Biomedicine and Deliberative Governance : Patents as Discourse on Life ( Routledge 2014 ) Austin Smith , ' No to Ban on Stem - cell Patents ' ( 2011 ) 472 ( 7344 ) Nature 418 ...
A unique collection of legal, religious, ethical, and political perspectives on debates surrounding biotechnology patents or 'patents on life'.
In Fungible Life Aihwa Ong explores the dynamic world of cutting-edge bioscience research, offering critical insights into the complex ways Asian bioscientific worlds and cosmopolitan sciences are entangled in a tropical environment ...
Kathrin Braun introduces the concept of »injuries of normality« to capture the specifics of this type of human rights violation and the respective struggles for historic justice.
When educational reformers engage in processes of rendering technical, they imagine learning environments as if they were apolitical and culturally neutral spaces that experts can design, manipulate, and ideally replicate; ...
Introduction -- Defining the public interest in the US and European patent systems -- Confronting the questions of life-form patentability -- Commodification, animal dignity, and patent-system publics -- Forging new patent politics through ...
The first part of the book focuses on biodiversity and examines what we are losing, why and what is to be done. The second part addresses biotechnology and looks at whether it is part of the solution or part of the problem, or perhaps both.
This book develops a sociological understanding of law making in the European Union.